Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial

BACKGROUND: Chronic pelvic pain affects 2–24% of women worldwide and evidence for medical treatments is scarce. Gabapentin is effective in treating some chronic pain conditions. We aimed to measure the efficacy and safety of gabapentin in women with chronic pelvic pain and no obvious pelvic patholog...

Descripción completa

Detalles Bibliográficos
Autores principales: Horne, Andrew W, Vincent, Katy, Hewitt, Catherine A, Middleton, Lee J, Koscielniak, Magda, Szubert, Wojciech, Doust, Ann M, Daniels, Jane P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527829/
https://www.ncbi.nlm.nih.gov/pubmed/32979978
http://dx.doi.org/10.1016/S0140-6736(20)31693-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527829/
https://www.ncbi.nlm.nih.gov/pubmed/32979978
http://dx.doi.org/10.1016/S0140-6736(20)31693-7

Ejemplares similares